Home » News Feeds
News Feeds
Patient safety, news and press releases from EMA
- Tue, 22 Apr 2014 13:15:00 +0000: News and press releases: EC/EMA-FDA bilateral – update – Patient safety, news and press releases: human and vet
Senior leadership from DG Health and Consumers (European Commission), the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) discussed a number of key initiatives at a bilateral meeting which took place in London from 31 March to 1 April 2014.
- Thu, 17 Apr 2014 15:41:00 +0000: News and press releases: European Medicines Agency update on stolen vials of Herceptin – Patient safety, news and press releases: human and vet
This is an update from the European Medicines Agency on the latest information relating to the stolen vials of Herceptin (trastuzumab) in Italy.
- Wed, 16 Apr 2014 11:00:00 +0000: News and press releases: European Medicines Agency alerts EU healthcare professionals after vials of falsified Herceptin identified – Patient safety, news and press releases: human and vet
The European Medicines Agency (EMA) has been informed that vials of the cancer medicine Herceptin (trastuzumab), thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into the supply chain in some countries.
- Wed, 16 Apr 2014 10:30:00 +0000: News and press releases: EMA and EU national competent authorities agree on action plan to address medication errors – Patient safety, news and press releases: human and vet
The European Medicines Agency and the National Competent Authorities of the European Union (EU) have agreed an action plan to address the issue of medication errors, a major public-health burden.
- Tue, 15 Apr 2014 13:10:00 +0000: News and press releases: European Medicines Agency closed 17-21 April 2014 – Patient safety, news and press releases: human and vet
The European Medicines Agency will be closed from 18:30 on Wednesday 16 April and will re-open at 7:30 on Tuesday 22 April 2014.
MedWatch Safety Alert RSS Feed
- Thu, 24 Apr 2014 14:40:00 +0000: Super Arthgold by Nano Well-being Health: Recall – Undeclared Drug Ingredients – MedWatch Safety Alert RSS Feed
Risk of myocardial infarction, stroke, congestive heart failure, renal toxicity, and bleeding, ulceration, or perforation of the stomach or intestines.
- Wed, 23 Apr 2014 15:00:00 +0000: Epidural Corticosteroid Injection: Drug Safety Communication – Risk of Rare But Serious Neurologic Problems – MedWatch Safety Alert RSS Feed
Injection of corticosteroids into the epidural space of the spine may result in loss of vision, stroke, paralysis, and death.
- Tue, 22 Apr 2014 21:09:00 +0000: Marcaine (Bupivacaine HCI Injection, USP) 0.25 percent, 10 ml, Single-Dose, Preservative-Free Vial: Recall – Visible Particulates – MedWatch Safety Alert RSS Feed
Injected particulate could result in local inflammation, mechanical disruption of tissue or immune response to the particulate.
- Fri, 18 Apr 2014 17:40:00 +0000: Thinogenics Products by Nature’s Universe: Recall – Undeclared Drug Ingredient – MedWatch Safety Alert RSS Feed
Use of undeclared sibutramine can lead to increased risk of seizures, heart attacks, arrhythmia and stroke.
- Fri, 18 Apr 2014 15:55:00 +0000: Propofol Injectable Emulsion, USP by Hospira: Recall – Visible Particulates – MedWatch Safety Alert RSS Feed
Injected particulate matter may result in local inflammation, phlebitis, and/or low level allergic response through mechanical disruption of tissue or immune response to the particulate.